Downregulation of Nrf2 and its dependent genes by SARS-CoV-2 infection exacerbates pulmonary inflammation and disease and therefore activation of Nrf2 appears to be an important element of the therapeutic approach during both chronic and acute SARS-CoV-2 infection (323, 324). The gene discussed is NFE2L2; the disease is inflammation.